Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Publication year range
1.
J Vet Pharmacol Ther ; 39(2): 205-8, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26270353

ABSTRACT

The objective of this study was to evaluate the disposition kinetics of enrofloxacin (ENR) in the plasma and its distribution in the muscle tissue of Nile tilapia (Oreochromis niloticus) after a single oral dose of 10 mg/kg body weight via medicated feed. The fish were kept at a temperature between 28 and 30 °C. The collection period was between 30 min and 120 h after administration of the drug. The samples were analyzed by high-performance liquid chromatography with a fluorescence detector (HPLC-FLD). The ENR was slowly absorbed and eliminated from the plasma (Cmax = 1.24 ± 0.37 µg/mL; Tmax = 8 h; T1/2Ke  = 19.36 h). ENR was efficiently distributed in the muscle tissue and reached maximum values (2.17 ± 0.74 µg/g) after 8 h. Its metabolite, ciprofloxacin (CIP), was detected and quantified in the plasma (0.004 ± 0.005 µg/mL) and muscle (0.01 ± 0.011 µg/g) for up to 48 h. After oral administration, the mean concentration of ENR in the plasma was well above the minimum inhibitory concentrations (MIC50 ) for most bacteria already isolated from fish except for Streptococcus spp. This way the dose used in this study allowed for concentrations in the blood to treat the diseases of tilapia.


Subject(s)
Animal Feed/analysis , Anti-Bacterial Agents/pharmacokinetics , Cichlids/blood , Fluoroquinolones/pharmacokinetics , Administration, Oral , Animals , Anti-Bacterial Agents/administration & dosage , Area Under Curve , Cichlids/metabolism , Ciprofloxacin/blood , Ciprofloxacin/metabolism , Enrofloxacin , Fluoroquinolones/administration & dosage , Half-Life , Muscle, Skeletal/chemistry
2.
J Vet Pharmacol Ther ; 36(6): 594-602, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23464606

ABSTRACT

Defining the pharmacokinetic parameters and depletion intervals for antimicrobials used in fish will help in the development of important guidelines for future regulations by Brazilian agencies on the use of these substances in fish farming. This paper presents a depletion study for enrofloxacin (ENR) and its main metabolite, ciprofloxacin (CIP), in pacu (Piaractus mesopotamicus) fillets. The depletion study was carried out under monitored environmental conditions, with the temperature controlled at 27 °C to mimic the fish farming conditions in Brazil. ENR was administered orally via medicated feed for 10 consecutive days at daily dosages of 10 mg/kg body weight (b.w.). The fish were slaughtered at 6, 12, and 24 h and 2, 3, 5, 8, 12, 17, and 24 days after the medication period. Considering a maximum residue limit of 100 µg/kg for the sum of the ENR and CIP residues in the fillet, the results obtained in the depletion study allowed the estimation of a half-life for ENR of 2.75 days and a withdrawal period of 23 days. The results obtained in this study are important for the farming of pacu in tropical regions.


Subject(s)
Anti-Bacterial Agents/pharmacokinetics , Characiformes/metabolism , Drug Residues , Fluoroquinolones/pharmacokinetics , Animals , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/metabolism , Ciprofloxacin/chemistry , Ciprofloxacin/metabolism , Ciprofloxacin/pharmacokinetics , Enrofloxacin , Fluoroquinolones/chemistry , Fluoroquinolones/metabolism , Half-Life , Muscle, Skeletal/chemistry
3.
J Vet Pharmacol Ther ; 35(1): 90-6, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21470247

ABSTRACT

Defining pharmacokinetic parameters and depletion intervals for antimicrobials used in fish represents important guidelines for future regulation by Brazilian agencies of the use of these substances in fish farming. This article presents a depletion study for oxytetracycline (OTC) in tilapias (Orechromis niloticus) farmed under tropical conditions during the winter season. High performance liquid chromatography, with fluorescence detection for the quantitation of OTC in tilapia fillets and medicated feed, was developed and validated. The depletion study with fish was carried out under monitored environmental conditions. OTC was administered in the feed for five consecutive days at daily dosages of 80 mg/kg body weight. Groups of ten fish were slaughtered at 1, 2, 3, 4, 5, 8, 10, 15, 20, and 25 days after medication. After the 8th day posttreatment, OTC concentrations in the tilapia fillets were below the limit of quantitation (13 ng/g) of the method. Linear regression of the mathematical model of data analysis presented a coefficient of 0.9962. The elimination half-life for OTC in tilapia fillet and the withdrawal period were 1.65 and 6 days, respectively, considering a percentile of 99% with 95% of confidence and a maximum residue limit of 100 ng/g. Even though the study was carried out in the winter under practical conditions where water temperature varied, the results obtained are similar to others from studies conducted under controlled temperature.


Subject(s)
Anti-Bacterial Agents/pharmacokinetics , Drug Residues , Oxytetracycline/pharmacokinetics , Tilapia/metabolism , Animal Feed , Animal Husbandry , Animals , Anti-Bacterial Agents/administration & dosage , Aquaculture , Brazil , Oxytetracycline/administration & dosage
4.
Article in English | MEDLINE | ID: mdl-21462582

ABSTRACT

A method for the simultaneous determination of flumequine, oxolinic acid, sarafloxacin, danofloxacin, enrofloxacin, and ciprofloxacin in tilapia (Orechromis niloticus) fillet, using high-performance liquid chromatography with fluorescence detection (HPLC-FLD) is presented. The quinolones were extracted from the food matrix with a solution of 10% trichloroacetic acid and methanol (80:20 v/v). Clean-up of the extract was performed using polymeric solid-phase extraction cartridges. Identification of the quinolones was confirmed by liquid chromatography-tandem mass spectrometry. The HPLC-FLD method was validated in-house and the following analytical parameters were obtained: linearity higher than 0.99 for all the quinolones; intra- and interassay precisions were lower than 3.5% and 10.9%, respectively; and recoveries ranged from 73% to 110%. The limit of quantification was below the maximum residue limit established by the Joint Expert Committee on Food Additives (JECFA), which indicates that the method is appropriate for the determination of quinolones in fish fillet.


Subject(s)
Chromatography, High Pressure Liquid/methods , Chromatography, Liquid/methods , Drug Residues/chemistry , Fluoroquinolones/chemistry , Tandem Mass Spectrometry/methods , Tilapia/metabolism , Animals , Anti-Bacterial Agents/chemistry , Fluorescence , Food Analysis/methods
5.
J Vet Pharmacol Ther ; 29(5): 365-72, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16958780

ABSTRACT

The pharmacokinetics of enrofloxacin (ENRO), a fluoroquinolone antimicrobial agent, was studied in male broiler chickens (Cobb) after single oral administration of 10 mg of ENRO/kg b.w. A high-performance liquid chromatography-photodiode array detector (DAD) (HPLC-DAD) method was developed and validated and used for quantitation of ENRO and its major metabolite ciprofloxacin in plasma. The HPLC analyses were carried out using a cationic-octadecyl mixed column and 0.05 mol/L phosphate buffer (pH 2.5)/acetonitrile as mobile phase. The sample preparation of plasma consisted of the precipitation of proteins followed by solid phase extraction on cationic-octadecyl mixed cartridges. The method was validated considering linear range, linearity, selectivity, sensitivity, limit of detection (LOD), limit of quantitation (LOQ), intra- and inter-day precisions and accuracy. The LOD and LOQ for both fluoroquinolones were 60 and 200 ng/mL for plasma. The plasma concentration vs. time graph was characteristic of a two-compartment open model. The maximal plasma concentration of 1.5 +/- 0.2 mg/mL was achieved at 9 +/- 2 h. The elimination half-life and the mean residence time of ENRO were 1.5 +/- 0.2 and 15.64 h, respectively. The area under the concentration-time curve was calculated as 35 +/- 4 mgxh/mL.


Subject(s)
Anti-Infective Agents/pharmacokinetics , Fluoroquinolones/pharmacokinetics , Administration, Oral , Animals , Anti-Infective Agents/administration & dosage , Area Under Curve , Chickens , Chromatography, High Pressure Liquid , Ciprofloxacin/blood , Enrofloxacin , Fluoroquinolones/administration & dosage , Half-Life , Male , Metabolic Clearance Rate
6.
Food Addit Contam ; 23(7): 668-73, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16751143

ABSTRACT

High-performance liquid chromatography (HPLC) with fluorescence detection was used for the quantification of ivermectin residues in bovine milk intended for human consumption. After liquid-liquid extraction of ivermectin and purification of the extract, the compound was derivatized with 1-methylimidazol in N,N-dimethyl formamide to form a fluorescent derivative, which was separated by HPLC, using reversed-phase C18, with methanol : water (96 : 4 v/v) mobile phase at a flow rate 0.7 ml min-1. The excitation and emission wavelengths of the fluorescence detector were adjusted at 360 and 470 nm, respectively. The linearity of the method was in the range 10-100 ng ivermectin ml-1. Based on a sample of 5.0 ml, the limit of detection and the limit of quantification for ivermectin in milk were 0.6 and 2 ng ml-1, respectively. The recovery rate varied from 76.4 to 87.2%, with an average of 77.9 +/- 3.2%, at four fortification levels. The inter-day precision of the method was 13% (n = 5). Of 168 samples analysed, 17.8% contained ivermectin above the limit of quantification. Nevertheless, none of the samples contained ivermectin above the maximum residue limit (10 ng ml-1) established by the Brazilian Ministry of Agriculture.


Subject(s)
Antiparasitic Agents/analysis , Drug Residues/analysis , Food Contamination/analysis , Ivermectin/analysis , Milk/chemistry , Animals , Brazil , Chromatography, High Pressure Liquid/methods , Food Analysis/methods
7.
Food Addit Contam ; 23(1): 93-9, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16393819

ABSTRACT

Packaging materials intended for direct food contact were acquired on the Brazilian retail market and analysed for their plasticizer content. Analyses were carried out by gas chromatography with flame ionization detection. Di-2-ethyl-hexyl adipate (DEHA), di-2-ethyl-hexyl phthalate (DEHP) and di-iso-decyl phthalate (DIDP) plasticizers were identified in films and closure seals in concentrations ranging from 12 to 19% (w/w), 15 to 44% (w/w) and 10 to 11% (w/w), respectively. Brazilian regulations state that for use with foods with a fat content above 5%, the levels of DEHP and DIDP in the plastic material should be no greater than 3%. The results obtained demonstrate a lack of conformity. It would be advisable to include information on the labels of packaging materials about their restrictions of use in order to advise manufacturers and consumers about their proper usage.


Subject(s)
Food Packaging/standards , Plasticizers/analysis , Adipates/analysis , Chromatography, Gas , Diethylhexyl Phthalate/analysis , Humans , Phthalic Acids/analysis , Polyvinyl Chloride/chemistry
8.
Food Addit Contam ; 22(12): 1203-8, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16356883

ABSTRACT

The nitrate content of leafy vegetables (watercress, lettuce and arugula) produced by different agricultural systems (conventional, organic and hydroponic) was determined. The daily nitrate intake from the consumption of these crop species by the average Brazilian consumer was also estimated. Sampling was carried out between June 2001 to February 2003 in Campinas, São Paulo State, Brazil. Nitrate was extracted from the samples using the procedure recommended by the AOAC. Flow injection analysis with spectrophotometric detection at 460 nm was used for nitrate determination through the ternary complex FeSCNNO+. For lettuce and arugula, the average nitrate content varied (p < 0.05) between the three agricultural systems with the nitrate level in the crops produced by the organic system being lower than in the conventional system that, in turn, was lower than in the hydroponic system. For watercress, no difference (p < 0.05) was found between the organic and hydroponic samples, both having higher nitrate contents (p < 0.05) than conventionally cultivated samples. The nitrate content for each crop species varied among producers, between different parts of the plant and in relation to the season. The estimated daily nitrate intake, calculated from the consumption of the crops produced by the hydroponic system, represented 29% of the acceptable daily intake established for this ion.


Subject(s)
Agriculture/methods , Nitrates/analysis , Vegetables/chemistry , Brassicaceae/chemistry , Brazil , Eating , Humans , Lactuca/chemistry , Nitrates/administration & dosage , Seasons
9.
Rev. bras. toxicol ; 17(2): 19-24, dez. 2004. ilus, tab
Article in Portuguese | LILACS | ID: lil-404060

ABSTRACT

Foi desenvolvido um método de análise por injeção em fluxo (FIA) com detector de fluorescência para determinação de oxitetraciclina (OTC), doxiciclina (DC) e tetraciclina (TC) em medicamentos veterinários. O sistema FIA foi otimizado com relação ao carregador (NaOH 2,5 10-3 mol L-1) e vazão (0,5 mL min-1). Os comprimentos de onda de excitação e emissão do detector foram 420 e 530 nm, respectivamente. O método foi validado mediante avaliação dos seguintes parâmetros: faixa linear (0,02 a 0,15 mg mL-1), linearidade r(OTC) 0,9975; r(DC) 0,9903; e r(TC) 0,9913; precisão intra- e inter-ensaio (RSD < 1,0 por cento e < 3,0 por cento, respectivamente), detectabilidade (120 ng), exatidão (98 a 104 por cento) e freqüência de amostragem (50 injeções h-1). Na determinação de tetraciclinas em preparações farmacêuticas, disponíveis no comércio, foi verificada variação de 90 a 104 por cento, na quantidade nominal de princípio ativo presente no medicamento


Subject(s)
Animals , Cattle , Drug Evaluation/methods , Drug Evaluation/veterinary , Doxycycline , Oxytetracycline , Tetracyclines , Flow Injection Analysis/methods , Flow Injection Analysis , Flow Injection Analysis/veterinary , Drug Utilization , Fluoroimmunoassay
SELECTION OF CITATIONS
SEARCH DETAIL
...